Pharmaceutical care for a case of infective endocarditis caused by Micrococcus luteus complicated with severe pneumonia
- VernacularTitle:1例藤黄微球菌致感染性心内膜炎合并重症肺炎的药学监护
- Author:
Siyun WANG
1
;
Junjun CHEN
1
;
Yuhui ZHU
1
;
Xin LI
1
;
Xinru ZHANG
1
Author Information
1. Dept. of Pharmacy，the Second Hospital of Jilin University，Changchun 130041，China
- Publication Type:Journal Article
- Keywords:
Micrococcus luteus;
infective endocarditis;
severe pneumonia;
pharmaceutical care;
clinical pharmacist
- From:
China Pharmacy
2023;34(9):1137-1141
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To provide ideas and reference for the treatment and pharmaceutical care of infective endocarditis （IE） caused by Micrococcus luteus complicated with severe pneumonia. METHODS The clinical pharmacist participated in the treatment of a patient with IE caused by M. luteus complicated with severe pneumonia； all anti-infective treatment plans were agreed upon after the doctor invited the clinical pharmacist for consultation. After the implementation of the plan， the clinical pharmacist conducted pharmaceutical care of effectiveness and safety for the plan， including adopting suitable drug， adjusting the dose of vancomycin by using parameters such as steady-state valley concentration and creatinine clearance rate， monitoring renal function and adverse drug reactions. RESULTS IE caused by M. luteus was cured after surgery and full treatment with anti-bacterial drugs， the severe pneumonia was improved， and the decline of renal function caused by drugs and the primary disease were recovered； clinical pharmacists had ensured the effect of anti-infection treatment by assisting in the formulation of treatment plans and the implementation of pharmaceutical care， avoiding further renal damage and solving the problem of cefoperazone sulbactam- related drug fever. CONCLUSIONS IE caused by M. luteus is relatively serious， and the treatment drug can be vancomycin and rifampicin. During the treatment， it is necessary to monitor the renal function， and adjust the dose of vancomycin or change other drugs； anti-infection pharmaceutical care provided by clinical pharmacists can guarantee the effectiveness and safety of anti- infection plan， and avoid the occurrence of severe adverse drug reactions.
